Subscribe to Life Science Success for cutting-edge insights, expert interviews, and a vibrant community. Your subscription fuels our mission and keeps you at the forefront of life sciences.
In this episode of Life Science Success, my guest is Dr. Jim Woody, CEO of 180 Life Sciences.Dr. Woody leads a pioneering team of scientific innovators at 180 Life Sciences, a clinical stage biotechnology company with three families of novel biologic...
In this episode of Life Science Success, my guest is Dr. Jim Woody, CEO of 180 Life Sciences.Dr. Woody leads a pioneering team of scientific innovators at 180 Life Sciences, a clinical stage biotechnology company with three families of novel biologic drugs that address separate areas of inflammation, fibrosis and pain.
Background and Career: Dr. Jim Woody is a pediatric immunologist with a diverse career, including military service and venture capital experience. He was instrumental in the development of anti-TNF drugs, a class of biologics with a market value of about $40 billion per year.
Focus on Patient-Centricity: Dr. Woody emphasizes the importance of patient benefit in drug development. He served on the board of Stanford Children's Hospital and aims to develop therapies that significantly improve patients' lives.
Current Work at 180 Life Sciences: The company is focused on finding new indications for anti-TNF drugs. They are working on conditions like Dupuytren's contracture, frozen shoulder, and post-operative dementia, aiming to prevent disability and improve quality of life.
Challenges and Future Plans: Regulatory hurdles and clinical trials are the next steps for 180 Life Sciences. Dr. Woody estimates that drug approvals could take a couple of years, depending on feedback from agencies like the FDA.
Personal Insights: Dr. Woody advises aspiring professionals to seize new opportunities and emphasizes the role of luck in biotechnology. He is excited about the next generation of anti-inflammatory agents that could offer more targeted treatments.
Please check out our Life Science Success Resources. You will find tools that will support growing companies and books for authors I have interviewed.
CEO & Director, 180 Life Sciences
Dr. Woody has served as our Chief Executive Officer and as a director since the Closing of the Business Combination in November 2020. Dr. Woody has served as the CEO of 180 since July 2020, and as a director of 180 since September 2020. Dr. Woody was a founder and served as Chairman of the Board of Directors for Viracta Pharmaceuticals, a lymphoma therapeutic company (July 2014 to December 2020). With the company undergoing a reverse merger into a public company, he resigned his Board member position and continues as a Board observer. He served as a General Partner of Latterell Venture Partners (February 2006 to December 2019) then moved to a Venture Partner position, for the one remaining LVP legacy company, PerceptiMed, a Pharmacy management company, where he continues to serve on the Board as they plan their IPO. He served as an interim CEO for MaraBio Systems Inc., a startup autism diagnostic company, from November 2018 to December 2022, when a new full time CEO was selected. He continues to serve as Vice Chairman, on the Board of Directors. He also serves as Chairman of the Board for Enosi Life Sciences, a next generation TNF inhibitor company, which position he has held since July 2020. He served as a Board member of IntegenX Inc. (2012 to 2018), and Neuraltus Pharmaceuticals, Inc. (February 2009 to December 2019). Dr. Woody was the founding CEO and Chairman of the Board of OncoMed Pharmaceuticals, Inc. (2004 to 2014), a NASDAQ listed company with a focus on antibodies targeting cancer stem cells. He previously served as a member of the Board of Directors of Prote… Read More
This week on the Life Science Success podcast, my guest is Thomas Farb-Horch. Thomas is the CEO of Thrive Bio. He has been involved in the founding of 18 pharmaceutical, biotech, medtech, software, and AI companies, 7 of which have …
In this episode of Life Science Success, my guest is Cristian Massacesi MD. Cristian is the Chief Medical Officer & Oncology Chief Development Officer at AstraZeneca. In the interview, we will discuss his start in oncology, his career...
This week on Life Science Success, we are thrilled to welcome back Elizabeth Smalley as our guest. Elizabeth is the VP, Product Management, Data & Analytics at ArisGlobal, where she plays a pivotal role in steering the company’s strategic...
In this episode of Life Science Success, host Don Davis has a conversation with Dr. Mohit Jain, a physician scientist with extensive experience in physiology, biomedicine, and mass spectrometry. Dr. Jain shares his unique journey from clinical...
In this episode of the Life Science Success Podcast, host Don Davis interviews Christian Engstrom, CEO of Bullpen, an elite club focused on fostering collaborative success in the life sciences industry. They discuss Christian's background, his...
Tushar Pandey is a distinguished expert in the Life Sciences industry, currently making significant strides at SimBioSys with his innovative approach to healthcare technology. His contributions have been pivotal in advancing medical solutions and...
In this episode of Life Science Success, my guest is William Hind. William, the founder of Alpharmaxim, is transforming how pharma companies communicate their value to healthcare providers. In this episode of Life Science Success, host Don interviews...
